Antimicrobial Resistance Trends of the Most Common Causative Pathogens Associated with Community-acquired Respiratory Infections in China: 2009–2018

Background Emergence of antimicrobial resistance poses new challenges in the management of community acquired respiratory tract infections (CARTIs). Therefore, surveillance on the antimicrobial susceptibilities of common respiratory pathogens is valuable and guides empirical therapeutic choices in management of CARTIs. Objective The objective of the current study is to summarize the antimicrobial resistance trends in common respiratory tract pathogens isolated from patients with CARTIs in China, over a 10-year period (2009–2018). Methods Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis strains were collected from multicenter, and antimicrobial susceptibility testing was performed in the research central laboratory of each study period from 2009–2018. The pathogens that accounted for CARTIs in the adult population was considered and summarized. Results From 2009–2018 a total of 3750 isolates were collected from 22 cities located across different regions of China. Among these the most common bacterial isolates include S. pneumoniae (53.7%) followed by H. influenza (32.4%), M. catarrhalis (13.9%). S. pneumoniae exhibited reduction in susceptibility and increase in resistance to penicillin, cephalosporins (cefaclor, cefuroxime, ceftriaxone) during the surveillance period. Invasive and noninvasive S. pneumoniae showed similar resistance. In the case of H. influenzae susceptibility to β-lactam and β-lactamase inhibitors (ampicillin, amoxicillin and AMC), SXT, clarithromycin and cephalosporins (cefuroxime, cefaclor, ceftazidime) was reduced over the past 10 years with an exception of ceftriaxone. Overall, moxifloxacin and levofloxacin have the highest susceptibility rates against S. pneumoniae (>95%) and H. influenza (>90%). M. catarrhalis exhibited susceptibility to almost all the tested antimicrobials. Conclusion In China the 10-year trends showed a substantial increase in resistance to β-lactam drugs and reduction in sensitivity. However, certain antimicrobial agents namely fluoroquinolones including moxifloxacin and levofloxacin maintained low resistance rates with better susceptibility. Further, with few exceptions decline in susceptibility rates to macrolides and cephalosporins was observed among the tested pathogens.

[1]  Jie Tian,et al.  Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine on All-Cause Pneumonia in Children Under 5 Years in Shanghai, China: A Real-World Study , 2022, SSRN Electronic Journal.

[2]  B. Gessner,et al.  Effectiveness of 13-valent pneumococcal conjugate vaccine against community acquired pneumonia among children in China, an observational cohort study. , 2021, Vaccine.

[3]  E. Motonaga,et al.  Clinical characteristics of community-acquired pneumonia due to Moraxella catarrhalis in adults: a retrospective single-centre study , 2020, BMC Infectious Diseases.

[4]  Qi Wang,et al.  Investigation of Antibiotic Resistance, Serotype Distribution, and Genetic Characteristics of 164 Invasive Streptococcus pneumoniae from North China Between April 2016 and October 2017 , 2020, Infection and drug resistance.

[5]  A. Davis,et al.  Diagnosis and Treatment of Adults With Community-Acquired Pneumonia. , 2020, JAMA.

[6]  M. Ip,et al.  Antibiotic-Resistant Community-Acquired Bacterial Pneumonia. , 2019, Infectious disease clinics of North America.

[7]  M. Fine,et al.  Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America , 2019, American journal of respiratory and critical care medicine.

[8]  Yonghong Xiao Antimicrobial Stewardship in China: Systems, Actions and Future Strategies. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  B. Cao,et al.  Phenotypic and Genotypic Characterization of Carbapenem-resistant Enterobacteriaceae: Data From a Longitudinal Large-scale CRE Study in China (2012-2016). , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  Juan Yang,et al.  The landscape of vaccines in China: history, classification, supply, and price , 2018, BMC Infectious Diseases.

[11]  J. Hinds,et al.  Carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in Indonesian children: A cross-sectional study , 2018, PloS one.

[12]  J. Gerber,et al.  Macrolides in Children With Community-Acquired Pneumonia: Panacea or Placebo? , 2018, Journal of the Pediatric Infectious Diseases Society.

[13]  B. Cao,et al.  Diagnosis and treatment of community‐acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association , 2017, The clinical respiratory journal.

[14]  B. Cao,et al.  Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates from 17 Chinese cities from 2011 to 2016 , 2017, BMC Infectious Diseases.

[15]  K. Huh,et al.  Community-Acquired Pneumonia in the Asia-Pacific Region , 2016, Seminars in Respiratory and Critical Care Medicine.

[16]  K. Bush,et al.  β-Lactams and β-Lactamase Inhibitors: An Overview. , 2016, Cold Spring Harbor perspectives in medicine.

[17]  C. D. Dela Cruz,et al.  Pneumococcal Vaccination Strategies. An Update and Perspective. , 2016, Annals of the American Thoracic Society.

[18]  B. Cao,et al.  Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated from community-acquired respiratory tract infections in China: Results from the CARTIPS Antimicrobial Surveillance Program. , 2016, Journal of global antimicrobial resistance.

[19]  A. Pantosti,et al.  Antimicrobial resistance: a global multifaceted phenomenon , 2015, Pathogens and global health.

[20]  J. Campos,et al.  Isolates of β-lactamase-negative ampicillin-resistant Haemophilus influenzae causing invasive infections in Spain remain susceptible to cefotaxime and imipenem. , 2014, The Journal of antimicrobial chemotherapy.

[21]  Ulysses W. Sallum,et al.  Rapid optical determination of β-lactamase and antibiotic activity , 2014, BMC Microbiology.

[22]  B. Thakuria,et al.  The Beta Lactam Antibiotics as an Empirical Therapy in a Developing Country: An Update on Their Current Status and Recommendations to Counter the Resistance against Them. , 2013, Journal of clinical and diagnostic research : JCDR.

[23]  B. Cao,et al.  Antimicrobial susceptibility of bacterial pathogens associated with community-acquired respiratory tract infections in Asia: report from the Community-Acquired Respiratory Tract Infection Pathogen Surveillance (CARTIPS) study, 2009-2010. , 2011, International journal of antimicrobial agents.

[24]  Y. Li,et al.  Molecular characterization of erm(B)‐ and mef(E)‐mediated erythromycin‐resistant Streptococcus pneumoniae in China and complete DNA sequence of Tn2010 , 2011, Journal of applied microbiology.

[25]  Hadley Wickham,et al.  ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .

[26]  M. Kaku,et al.  Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1-5 (1999-2004). , 2008, Microbial drug resistance.

[27]  Samir N. Patel,et al.  Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guideline , 2006 .

[28]  Li Youning,et al.  Resistance Phenotypes and Genotypes of Erythromycin-Resistant Streptococcus pneumoniae Isolates in Beijing and Shenyang, China , 2004, Antimicrobial Agents and Chemotherapy.

[29]  M. Ferraro Performance standards for antimicrobial susceptibility testing , 2001 .

[30]  J. Waitz Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .

[31]  K J Ryan,et al.  Antimicrobial Susceptibility Testing , 2016, Advances in Experimental Medicine and Biology.